๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer

โœ Scribed by Cynthia G. Leichman; Kari Chansky; John S. Macdonald; Michael A. Doukas; G. Thomas Budd; Jeffrey K. Giguere; James L. Abbruzzese

Book ID
110398106
Publisher
Springer US
Year
2002
Tongue
English
Weight
71 KB
Volume
20
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II trial of interferon-ฮฑ and 5-f
A phase II trial of interferon-ฮฑ and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
โœ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 355 KB ๐Ÿ‘ 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

Phase II study of 5-fluorouracil and fol
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study
โœ Giuseppe Colucci ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 3 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our